Genetic Diversity and Adaptation
Analytical deep dive — question counts, mark distribution, mastery curves, command-word breakdowns, and examiner narrative analysis.
3.4.4 (Genetic Diversity and Adaptation) appeared in 6 of the 8 years between 2017 and 2024, contributing 14 questions and 34 marks across Papers 1, 2 and 3. APPLICATION dominates the mark distribution at 50.0% of total marks. The accessibility–mastery gap sits at 27.9 percentage points (57.7% vs 29.8%) — most students reach partial credit, but full marks remain harder to secure. Mastery varied year-to-year, lowest in 2018 (10.0%) and highest in 2017 (39.7%).
| Year | Questions | Total marks | Mean accessibility | Mean mastery |
|---|---|---|---|---|
| 2017 | 3 | 7 | 61.7% | 39.7% |
| 2018 | 1 | 3 | 55.0% | 10.0% |
| 2019 | 3 | 7 | 38.3% | 20.0% |
| 2020 | 0 | 0 | — COVID | — COVID |
| 2021 | 0 | 0 | — COVID | — COVID |
| 2022 | 2 | 6 | 72.5% | 20.0% |
| 2023 | 2 | 5 | 57.5% | 35.0% |
| 2024 | 0 | 0 | — COVID | — COVID |
| Term | Times credited | Years | Notes |
|---|---|---|---|
| reproduce | 3 | 2017, 2019, 2025 | |
| alleles | 3 | 2018, 2019, 2022 |
| Term | Times credited | Years | Notes |
|---|---|---|---|
| frequency | 5 | 2019, 2022 | |
| survive | 2 | 2019, 2025 | |
| selection pressure | 2 | 2022, 2023 | |
| proportion | 2 | 2022 | |
| percentage | 2 | 2022 | |
| allele frequency increases | 2 | 2023, 2025 |
| Term | Times rejected | Years | Why rejected |
|---|---|---|---|
| immune bacteria | 1 | 2017 | |
| use of both antibiotics will be more effective (insufficient) | 1 | 2017 | |
| environment changed | 1 | 2018 | |
| selective advantage (without context) | 1 | 2018 | |
| 'number' for 'frequency' | 1 | 2018 | |
| number (for frequency); survive without reproducing link | 1 | 2019 | |
| correlation coefficient (continuous data); Student's t-test (comparing means of two datasets) | 1 | 2019 | |
| disprove/wrong/incorrect (null hypothesis); 'results due to chance'; 'number' for 'frequency' | 1 | 2019 | |
| antibiotics cause production of resistance gene/allele | 1 | 2022 | |
| reference to immunity only | 1 | 2022 | |
| to see if results are significant | 1 | 2022 | |
| 61% of 229 million directly; 67% of 229 million | 1 | 2023 | |
| 'resistance gene' (must be allele) | 1 | 2023 | |
| 'mutation caused by infection' | 1 | 2023 | |
| 'desired characteristics' | 1 | 2023 |
- Antibiotics described as causing production of a resistance gene or allele — the resistance allele pre-exists in the population; antibiotics act as a selection pressure that kills non-resistant bacteria, leaving the already-resistant individuals to reproduce; stating that the antibiotic causes the mutation or generates the allele is a fundamental mechanistic error that was penalised across 2017 and 2022 (2017 P1 Q05.5, 2022 P1 Q02.1)
- "Immune" used to describe resistant bacteria — immunity is an acquired response by the immune system; antibiotic resistance is a heritable allele difference, not an immune mechanism; "immune bacteria" was explicitly rejected throughout this sub-section, including in 2017 (2017 P1 Q05.5)
- Natural selection described without linking survival to reproduction and allele frequency — in 2019, answers that described bacteria surviving in the presence of antibiotics without explicitly stating that survivors reproduce to pass on the resistance allele earned partial credit at best; the full chain (selection pressure → differential survival → reproduction → increased allele frequency) was required (2019 P1 Q04.1)
- The null hypothesis described as "disproved" or "wrong" — null hypotheses are rejected or accepted at a given significance level; they are never "disproved" or "proven"; this vocabulary error was penalised in 2019 and reflects confusion between statistical decision-making and scientific proof (2019 P1 Q04.4)
- "Gene" used where "allele" is required — the resistance is conferred by a specific allele (variant of a gene), not the gene itself; writing "resistance gene" instead of "resistance allele" conflates the locus with the variant and was explicitly rejected in 2022 and 2023 (2022 P1 Q02.1, 2023 P1 Q03.4)
- "Number" used instead of "frequency" when describing allele change over generations — AQA requires "frequency" to reflect proportional change across the population; "number" implies a raw count without reference to the total and was rejected multiple times across 2018, 2019, and 2022 (2018 P1 Q06.3, 2019 P1 Q04.1)
- "Selective advantage" stated without specifying what the advantage is against — the phrase alone earned no mark in 2018; the answer required stating what the organism survives (the antibiotic) and why this confers an advantage (other bacteria die) (2018 P1 Q06.3)
- Both antibiotics claimed to be "more effective" without a qualifying mechanism — in 2017, students who stated "using both antibiotics will be more effective" without explaining why (resistance to both simultaneously is less likely to arise, fewer surviving bacteria) earned no mark; the justification for the dual-treatment strategy was required, not just the assertion (2017 P1 Q05.5)
- Statistical test choice errors — in 2019, students suggested a correlation coefficient for a dataset requiring comparison of means, and a Student's t-test for a dataset requiring Spearman's rank; identifying which test suits which data type (continuous vs rank, comparison vs correlation) was the mark requirement (2019 P1 Q04.4)
- "Results due to chance" written in null hypothesis — same error pattern as in 3.4.3; the null hypothesis must reference the difference being due to chance, not the results themselves; rejected in 2019 (2019 P1 Q04.4)
The accessibility–mastery gap of 27.9 percentage points characterises this sub-section's difficulty profile. Most students reach partial credit; full marks remain harder to achieve. Within 3.4 (Genetic information, variation and relationships), 3.4.4 ranks 1 of 6 sub-sections by mean mastery (1 = hardest). Mastery trajectory is rising across the cohort window: 39.7% in 2017 → 39.3% in 2025 (-0.3 percentage points). Mean mastery was lowest in 2018 (10.0%) and highest in 2017 (39.7%).